blue cross blue shield glp 1 coverage cost plans reverse course on GLP-1 Michigan cuts off weight-loss drugs

The critical path to delivering new capacity runs through successful technology transfers between R&D, existing plants, and newly built facilities ( [17] ) ( [18] )

It is not approved by the FDA or any other regulatory agency for human therapeutic use

The FDA previously allowed compounded tirzepatide to be made due to a national shortage, but that shortage has been resolved, and pharmacies and outsourcing facilities are no longer allowed to compound, distribute, or dispense compounded GLP-1 medications, including tirzepatide

RETRACTED April 2025

A molecule that blocks the receptors activity normalized social behaviors and flexibility in spatial learning in a mouse model of dup15q syndrome

Insulin Pump Use Patients using an insulin pump are still receiving long-term insulin therapy